Vasodilator therapy for pulmonary hypertension in children: a national study of patient characteristics and current treatment strategies

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Naumburg Estelle) > Vasodilator therapy...

Jeremiasen, IdaLund University,Lunds universitet,Kärlväggsbiologi,Forskargrupper vid Lunds universitet,Barnkardiologi,Vessel Wall Biology,Lund University Research Groups,Children cardiology,Skåne University Hospital (författare)

Vasodilator therapy for pulmonary hypertension in children : a national study of patient characteristics and current treatment strategies

Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

2021-12
John Wiley & Sons,2021
electronicrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:umu-190848
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190848URI
https://doi.org/10.1177/20458940211057891DOI
https://lup.lub.lu.se/record/6f1cb0d8-6f02-4688-bda6-521f3c7fbe0eURI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Pulmonary vasodilator therapy is still often an off-label treatment for pulmonary hypertension in children. The aim of this nationwide register-based study was to assess patient characteristics and strategies for pulmonary vasodilator therapy in young Swedish children. Prescription information for all children below seven years of age at treatment initiation, between 2007 and 2017, was retrieved from the National Prescribed Drug Register, and medical information was obtained by linkage to other registers. All patients were categorized according to the WHO classification of pulmonary hypertension. In total, 233 patients had been prescribed pulmonary vasodilators. The treatment was initiated before one year of age in 61% (N = 143). Sildenafil was most common (N = 224 patients), followed by bosentan (N = 29), iloprost (N = 14), macitentan (N = 4), treprostinil (N = 2) and riociguat (N = 2). Over the study period, the prescription rate for sildenafil tripled. Monotherapy was most common, 87% (N = 203), while 13% (N = 20) had combination therapy. Bronchopulmonary dysplasia (N = 82, 35%) and/or congenital heart defects (N = 156, 67%) were the most common associated conditions. Eight percent (N = 18) of the patients had Down syndrome. Cardiac catheterization had been performed in 39% (N = 91). Overall mortality was 13% (N = 30) during the study period. This study provides an unbiased overview of national outpatient use of pulmonary vasodilator therapy in young children. Few cases of idiopathic pulmonary arterial hypertension were found, but a large proportion of pulmonary hypertension associated with congenital heart defects or bronchopulmonary dysplasia. Despite treatment, mortality was high, and additional pediatric studies are needed for a better understanding of underlying pathologies and evidence of treatment effects.

Ämnesord och genrebeteckningar

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Kardiologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems hsv//eng
bronchopulmonary dysplasia
pulmonary hypertension
children
congenital heart defect
sildenafil
bronchopulmonary dysplasia, pulmonary hypertension, children
congenital heart defect
sildenafil

Biuppslag (personer, institutioner, konferenser, titlar ...)

Naumburg, EstelleUmeå University,Umeå universitet,Pediatrik(Swepub:umu)esna0003 (författare)
Westöö, ChristianLund University,Lunds universitet,Kärlväggsbiologi,Forskargrupper vid Lunds universitet,Vessel Wall Biology,Lund University Research Groups(Swepub:lu)ch3810we (författare)
G. Weismann, ConstanceThe Paediatric Heart Center, Skane University Hospital, Lund, Sweden(Swepub:lu)co7116we (författare)
Tran-Lundmark, KarinLund University,Lunds universitet,Kärlväggsbiologi,Forskargrupper vid Lunds universitet,WCMM- Wallenberg center för molekylär medicinsk forskning,Medicinska fakulteten,Vessel Wall Biology,Lund University Research Groups,WCMM-Wallenberg Centre for Molecular Medicine,Faculty of Medicine,Skåne University Hospital(Swepub:lu)med-kt_ (författare)
KärlväggsbiologiForskargrupper vid Lunds universitet (creator_code:org_t)

Sammanhörande titlar

Ingår i:Pulmonary Circulation: John Wiley & Sons11:42045-89322045-8940

Internetlänk

Hitta via bibliotek

Pulmonary Circulation (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Jeremiasen, Ida; Naumburg, Estell ...; Westöö, Christia ...; G. Weismann, Con ...; Tran-Lundmark, K ...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Kardiologi

Artiklar i publikationen: Pulmonary Circul ...

Av lärosätet: Umeå universitet; Lunds universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se